R. H. Jones

3.1k total citations
67 papers, 2.5k citations indexed

About

R. H. Jones is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, R. H. Jones has authored 67 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 27 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Surgery. Recurrent topics in R. H. Jones's work include Diabetes Management and Research (15 papers), Metabolism, Diabetes, and Cancer (13 papers) and Pancreatic function and diabetes (13 papers). R. H. Jones is often cited by papers focused on Diabetes Management and Research (15 papers), Metabolism, Diabetes, and Cancer (13 papers) and Pancreatic function and diabetes (13 papers). R. H. Jones collaborates with scholars based in United Kingdom, United States and Germany. R. H. Jones's co-authors include A. Margot Umpleby, Roman Hovorka, Fariba Shojaee‐Moradie, David Russell‐Jones, Peter H. Sönksen, Nicola Jackson, Susan E. Ozanne, Jane L. Tarry‐Adkins, Ludovic J. Chassin and Ian J. Gowrie and has published in prestigious journals such as The Lancet, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

R. H. Jones

66 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. H. Jones United Kingdom 28 1.1k 715 576 537 317 67 2.5k
Keiichi Kodama United States 19 978 0.9× 698 1.0× 721 1.3× 595 1.1× 522 1.6× 31 2.9k
David R. McCance United Kingdom 34 2.2k 2.0× 920 1.3× 496 0.9× 503 0.9× 320 1.0× 101 4.1k
J D England United States 25 2.0k 1.8× 336 0.5× 632 1.1× 325 0.6× 512 1.6× 37 3.0k
M. Nazeem Nanjee United Kingdom 26 954 0.8× 1.3k 1.8× 421 0.7× 421 0.8× 93 0.3× 64 2.4k
Richard E. Reitz United States 25 1.0k 0.9× 445 0.6× 646 1.1× 278 0.5× 271 0.9× 46 2.9k
Michael Bryer‐Ash United States 29 975 0.9× 553 0.8× 947 1.6× 602 1.1× 393 1.2× 59 3.0k
Harald Klein Germany 30 946 0.8× 683 1.0× 1.2k 2.1× 679 1.3× 243 0.8× 106 2.7k
Brigitte M. Frey Switzerland 38 1.6k 1.4× 470 0.7× 1.2k 2.1× 276 0.5× 442 1.4× 96 3.6k
Juan J. Chillarón Spain 31 574 0.5× 521 0.7× 837 1.5× 254 0.5× 305 1.0× 100 3.1k
Ottavio Giampietro Italy 24 567 0.5× 325 0.5× 329 0.6× 364 0.7× 124 0.4× 144 2.0k

Countries citing papers authored by R. H. Jones

Since Specialization
Citations

This map shows the geographic impact of R. H. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. H. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. H. Jones more than expected).

Fields of papers citing papers by R. H. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. H. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. H. Jones. The network helps show where R. H. Jones may publish in the future.

Co-authorship network of co-authors of R. H. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of R. H. Jones. A scholar is included among the top collaborators of R. H. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. H. Jones. R. H. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Riyaz, Laura Pasea, Handrean Soran, et al.. (2022). Elevated plasma triglyceride concentration and risk of adverse clinical outcomes in 1.5 million people: a CALIBER linked electronic health record study. Cardiovascular Diabetology. 21(1). 102–102. 23 indexed citations
2.
Herring, Roselle, R. H. Jones, & David Russell‐Jones. (2013). Hepatoselectivity and the evolution of insulin. Diabetes Obesity and Metabolism. 16(1). 1–8. 54 indexed citations
3.
Mohiddin, Abdu, et al.. (2006). Sharing specialist skills for diabetes in an inner city: A comparison of two primary care organisations over 4 years. Journal of Evaluation in Clinical Practice. 12(5). 583–590. 12 indexed citations
4.
Angelis, Lorenita De, Sandrine Millasseau, Andrew H. Smith, et al.. (2004). Sex Differences in Age-Related Stiffening of the Aorta in Subjects With Type 2 Diabetes. Hypertension. 44(1). 67–71. 89 indexed citations
5.
Shojaee‐Moradie, Fariba, Paul Carroll, Ludovic J. Chassin, et al.. (2001). Partitioning glucose transport/distribution and disposal during euglycaemic clamp. Diabetologia. 44. 3 indexed citations
6.
Chang, Paul, et al.. (2000). Characterization of bovine collagens using capillary electrophoresis — an alternative to slab gel electrophoresis. Journal of Pharmaceutical and Biomedical Analysis. 22(6). 957–966. 14 indexed citations
7.
Shojaee‐Moradie, Fariba, et al.. (1995). Demonstration of a relatively hepatoselective effect of covalent insulin dimers on glucose metabolism in dogs. Diabetologia. 38(9). 1007–1013. 9 indexed citations
9.
Umpleby, A. Margot, Fariba Shojaee‐Moradie, Margaret J. Thomason, et al.. (1994). Effects of insulin‐like growth factor‐I (IGF‐I), insulin and combined IGF‐I‐insulin infusions on protein metabolism in dogs. European Journal of Clinical Investigation. 24(5). 337–344. 10 indexed citations
10.
nksen, Peter H. S ouml, David Russell‐Jones, & R. H. Jones. (1993). Growth Hormone and Diabetes mellitus. Hormone Research. 40(1-3). 68–79. 81 indexed citations
11.
Powrie, Jake, Fariba Shojaee‐Moradie, Gerald F. Watts, et al.. (1993). Effects of chloroquine on the dyslipidemia of non-insulin-dependent diabetes mellitus. Metabolism. 42(4). 415–419. 25 indexed citations
12.
Marshall, Julie A., Richard F. Hamman, Judith Baxter, et al.. (1993). Ethnic Differences in Risk Factors Associated with the Prevalence of Non-insulin-dependent Diabetes Mellitus. American Journal of Epidemiology. 137(7). 706–718. 54 indexed citations
13.
Saffran, Murray, et al.. (1991). Oral insulin in diabetic dogs. Journal of Endocrinology. 131(2). 267–278. 53 indexed citations
14.
Jones, R. H., et al.. (1986). Demonstration that the insulin receptor undergoes an early structural modification following insulin binding. Biochimica et Biophysica Acta (BBA) - Biomembranes. 856(2). 320–324. 1 indexed citations
15.
Nash, Robert J., E.Arthur Bell, George W. J. Fleet, R. H. Jones, & J. Michael Williams. (1985). The identification of a hydroxylated pyrrolidine derivative from Castanospermum australe. Journal of the Chemical Society Chemical Communications. 738–738. 32 indexed citations
16.
Jones, R. H., et al.. (1980). Radioimmunoassay of chemically modified insulins. Diabetologia. 18(1). 59–63. 2 indexed citations
17.
Gordon, Donald A., R. H. Jones, & Stephen Nowicki. (1979). A Measure of Intensity of Parental Punishment. Journal of Personality Assessment. 43(5). 485–496. 20 indexed citations
18.
Henderson, J.R., D.B. Jefferys, R. H. Jones, & Dragana Stanley. (1976). THE EFFECT OF ATROPINE ON THE INSULIN RELEASE CAUSED BY ORAL AND INTRAVENOUS GLUCOSE IN HUMAN SUBJECTS. European Journal of Endocrinology. 83(4). 772–780. 49 indexed citations
19.
Jones, R. H., et al.. (1974). Microbiological hydroxylation of steroids. Part XI. Convenient routes to 3,7-, 3,11-, 3,12-, 7,11-, 7,17-, and 11,17-dioxygenated 5α-androstanes and to 5α-androstan-11-one. Journal of the Chemical Society Perkin Transactions 1. 2(0). 312–317. 7 indexed citations
20.
Thomas, J. Hywel, et al.. (1973). The Effect of Insulin Deficiency on the Glutathione-Insulin Transhydrogenase Activity of Rat Liver. Biochemical Society Transactions. 1(5). 1179–1182. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026